The X-ray powder diffraction has variety applications in the pharmaceutical industry. The most popular is a polymorphs diagnostic of an active substance (API - Active Pharmaceutical Ingredient). If API has more than one crystalline form there is a risk that during following steps like: synthesis, milling, formulation and storage an undesirable form appears. For this reason powder diffraction is a main tool for qualitative and quantitative analysis.

The aim of this work was to apply the quantitative Rietveld analysis for an evaluation of API in few commercial drugs. For example, VFEND (Pfizer) tablets contain voriconazole as API. The inactive ingredients include: lactose monohydrate, pregelatinized starch, croscarmellose sodium, povidone, magnesium stearate. Voriconazole¹, lactose² and magnesium stearate are crystalline. The others ingredients are amorphous or semi-crystalline. Qualitative analysis detected only voriconazole and lactose. Relative phase amounts, in weight percent, are following: voriconazole 35.63%, lactose 47.39% and amorphous 16.98% (figure below). The calculated voriconazole content is close to the real quantity which is equal 30%.
Measurement time 60min. GOF 5.86, R_exp 1.15, R_wp 6.74, R_p 5.31.

Fig. Quantitative Rietveld analysis of VFEND.

References
¹⁾ K. Ravikumar, B. Sridhar, K. D. Prasad, A. K. S. B. Rao (2007) Acta Crystallogr., Sect. E.: Struct. Rep. Online, 63, o565,
²⁾ J. H. Noordik, P. T. Beurskens, P. Bennema, R. A. Visser, R. O. Gould (1984) Z. Kristallogr., 168, 59.

Acknowledgements
The X-ray measurements were undertaken in the Structural Research Laboratory at the Chemistry Department of the University of Warsaw.

• Legal notice:
  

  Copyright (c) Pielaszek Research, all rights reserved.
  The above materials, including auxiliary resources, are subject to Publisher's copyright and the Author(s) intellectual rights. Without limiting Author(s) rights under respective Copyright Transfer Agreement, no part of the above documents may be reproduced without the express written permission of Pielaszek Research, the Publisher. Express permission from the Author(s) is required to use the above materials for academic purposes, such as lectures or scientific presentations.
  In every case, proper references including Author(s) name(s) and URL of this webpage: https://science24.com/paper/16339 must be provided.

1. Improved manufacturing process of bosentan monohydrate.
2. Characterization of dutasteride polymorphic forms
3. Preparation and physicochemical properties of crystalline forms and amorphous pemetrexed disodium
4. Physicochemical characterization of sunitinib and its impurities
5. Distinguishing between polymorphic forms of linezolid by solid-phase electronic and vibrational circular dichroism
6. Preparation of protoaescigenin from escin.
7. Structural characterization of PX-S
8. High-yielded method of synthesis of voriconazole.
9. Optimization of AR-3 synthesis
10. CHARACTERIZATION OF ARIPIPRAZOLE SOLVATE WITH ETHANOL AND POLYMORPHIC FORMS PRODUCED DURING ITS HEATING
11. THE VALIDATION OF ANALYTICAL METHODS OF A PHARMACEUTICAL ACTIVE SUBSTANCE PRODUCED IN SMALL SCALE PLANT (SSP). THE EXAMPLE OF PIOGLITAZONE HYDROCHLORIDE.